|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 26.76 USD | -0.89% |
|
+0.02% | -8.18% |
| Market Cap | 3.38B 2.96B 2.73B 2.55B 4.8B 319B 4.91B 32.85B 12.68B 158B 12.68B 12.4B 547B | P/E 2026 * |
249x | P/E 2027 * | 27.1x |
|---|---|---|---|---|---|
| Enterprise Value | 3.11B 2.73B 2.52B 2.35B 4.42B 294B 4.52B 30.28B 11.69B 145B 11.69B 11.43B 504B | EV / Sales 2026 * |
6.26x | EV / Sales 2027 * | 4.33x |
| Free-Float |
98.2% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Arcutis Biotherapeutics, Inc.
| 1 day | -0.91% | ||
| 1 week | +0.02% | ||
| Current month | +24.25% | ||
| 1 month | +24.25% | ||
| 3 months | +25.01% | ||
| 6 months | -6.64% | ||
| Current year | -8.18% |
| 1 week | 26.12 |  | 28.38 |
| 1 month | 20.48 | | 28.38 |
| Current year | 19.3 | | 30.75 |
| 1 year | 13.06 | | 31.77 |
| 3 years | 1.76 | | 31.77 |
| 5 years | 1.76 | | 31.77 |
| 10 years | 1.76 | | 40.88 |
| Manager | Title | Age | Since |
|---|---|---|---|
Todd Watanabe
CEO | Chief Executive Officer | 58 | 2017-03-31 |
| Corporate Officer/Principal | 71 | 2025-12-02 | |
Latha Vairavan
DFI | Director of Finance/CFO | - | 2025-05-14 |
| Director | Title | Age | Since |
|---|---|---|---|
Patrick Heron
CHM | Chairman | 55 | 2019-11-30 |
Todd Watanabe
BRD | Director/Board Member | 58 | 2015-12-31 |
Howard Welgus
BRD | Director/Board Member | 74 | 2020-07-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06-16 | Sell | Director | -635 | 0.0005% | ||
| 06-14 | Sell | Director | -4,946 | 0.0040% | ||
| 06-04 | Free | Director | 22,445 | 0.0179% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.89% | +0.02% | +90.19% | +220.11% | 3.38B | |
| -0.77% | +2.60% | +19.69% | -11.30% | 64.39B | |
| +1.93% | +6.42% | +57.83% | +229.54% | 56.12B | |
| +7.82% | +44.80% | +44.80% | +44.80% | 40.54B | |
| +0.45% | -0.80% | -50.76% | -58.54% | 37.98B | |
| +0.08% | +8.45% | +72.46% | -23.23% | 31.89B | |
| +2.19% | +15.07% | +147.52% | -44.08% | 26.69B | |
| -0.55% | +9.36% | +66.46% | +83.29% | 22.73B | |
| +6.52% | +5.12% | +3.49% | +174.61% | 16.66B | |
| -0.77% | +4.00% | +60.51% | +123.05% | 16.6B | |
| Average | +1.61% | +5.83% | +51.22% | +73.83% | 31.7B | |
| Weighted average by Cap. | +1.69% | +5.83% | +42.68% | +54.95% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 497M 435M 402M 375M 706M 47B 722M 4.84B 1.87B 23.19B 1.87B 1.83B 80.5B | 646M 565M 522M 487M 918M 61.06B 939M 6.28B 2.43B 30.12B 2.43B 2.37B 105B |
| Net income | 15.18M 13.29M 12.27M 11.46M 21.56M 1.43B 22.06M 148M 56.99M 708M 56.99M 55.74M 2.46B | 134M 118M 109M 101M 191M 12.69B 195M 1.31B 504M 6.26B 504M 493M 21.74B |
| Net Debt | -265M -232M -214M -200M -376M -25.01B -384M -2.57B -993M -12.34B -994M -972M -42.84B | -580M -508M -469M -438M -824M -54.82B -843M -5.64B -2.18B -27.05B -2.18B -2.13B -93.9B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-06-29 | US$26.67 | -1.24% | 511,239 |
| 26-06-26 | US$27.00 | +1.16% | 3,711,679 |
| 26-06-25 | US$26.69 | -2.48% | 1,971,901 |
| 26-06-24 | US$27.37 | +4.19% | 2,069,683 |
| 26-06-23 | US$26.27 | -1.46% | 1,664,015 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ARQT Stock
Select your edition
All financial news and data tailored to specific country editions
